Dolby Laboratories (DLB) Cash & Equivalents (2009 - 2026)

Dolby Laboratories has reported Cash & Equivalents for 18 years, with the latest figure at $594.3 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 5.15% year-over-year to $594.3 million; the trailing twelve-month figure through Mar 2026 stood at $594.3 million (down 5.15% YoY), and the FY2025 full-year result was $701.9 million, up 45.61% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $594.3 million, down from $643.8 million in the prior quarter.
• The five-year high for Cash & Equivalents was $900.4 million in Q2 2022, with the low at $482.0 million in Q3 2024.
• Historically, Cash & Equivalents has averaged $681.2 million across 5 years, with a median of $688.4 million in 2023.
• Annual changes were most pronounced in 2022 — Cash & Equivalents plunged 49.39% — and 2025, when it surged 45.61%.
• Dolby Laboratories' Cash & Equivalents stood at $626.2 million in 2022, then gained by 4.9% to $656.8 million in 2023, then fell by 20.71% to $520.8 million in 2024, then advanced by 23.62% to $643.8 million in 2025, then dropped by 7.7% to $594.3 million in 2026.
• The last three Cash & Equivalents figures came in at $594.3 million (Q1 2026), $643.8 million (Q4 2025), and $701.9 million (Q3 2025), per Business Quant data.